References
- USP DI, 17th Ed. Rockville. 1997; Vol. 1: 714–720
- Levy R.H., Wilensky A.J., Anderson G.D. Carbamazepine, valproic acid, phenobarbital, and ethosuximide. Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring, 3rd Ed., W.E. Evans, J.J. Schentag, W.J. Jusko. Applied Therapeutics, Vancouver 1992; 26-1–26-29
- El-Nahhas S.A. Physico-chemical characteristics of carbamazepine-β-cyclodextrin inclusion compounds and carbamazepine-PEG solid dispersions. Pharmazie 1996; 51(12)960–963
- Betlach C.J., Gonzales M.A., McKiernan B.C., Neff-Davis C., Bodor N. Oral pharmacokinetics of carbamazepine in dogs from commercialtablets and a cyclodextrin complex. J. Pharm. Sci. 1993; 82(10)1058–1060
- Brewster M.E., Anderson W.R., Meinsma D., Moreno D., Webb A.I., Pablo L., Estes K.S., Derendorf H., Bodor N., Sawchuk R., Cheung B., Pop E. Intravenous and oral pharmacokinetics evaluation of a 2-hydroxypropyl-β-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. J. Pharm. Sci. 1997; 86(3)335–339
- El-Zein H., Riad L., El-Bary A.A. Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation. Int. J. Pharm. 1998; 168: 209–220
- Giunchedi P., Maggi L., Conte U., La Manna A. Linear extended release of a water-insoluble drug, carbamazepine, from erodible matrices. Int. J. Pharm. 1993; 94: 15–22
- Ikinci G., Capan Y., Senel S., Dalkara T., Hincal A.A. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets. Pharmazie 1999; 54(2)139–141
- Takenaka H., Kawashima Y., Lin S.-Y. Preparation of enteric-coated microcapsules for tableting by spray-drying technique and in vitro simulation of drug release from the tablet in GI tract. J. Pharm. Sci. 1980; 69(12)1388–1392
- Broadhead J., Rouan S.K.E., Rhodes C.T. The spray-drying of pharmaceuticals. Drug Dev. Ind. Pharm. 1992; 18(11–12)1169–1206
- Wan L.S.C., Heng P.W.S., Chia C.G.H. Spray drying as a process for microencapsulation and the effect of different coating polymers. Drug Dev. Ind. Pharm. 1992; 18(9)997–1011
- Kristmundsdóttir T., Gudmundsson Ó.S., Ingvarsdóttir K. Release of diltiazem from Eudragit microparticles prepared by spray-drying. Int. J. Pharm. 1996; 137: 159–165
- Palmieri G.F., Wehrlé P., Stamm A. Evaluation of spray-drying as a method to prepare microparticles for controlled drug release. Drug Dev. Ind. Pharm. 1994; 20(18)2859–2879
- Clarke N., O’Connor K., Ramtoola Z. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying. Drug Dev. Ind. Pharm. 1998; 24(2)169–174
- Ermis D., Yürksel A. Preparation of spray-dried microspheres of indomethacin and examination of the effects of coating on dissolution rates. J. Microencapsulation 1999; 16(3)315–324
- Wan L.S.C., Heng P.W.S., Chia C.G.H. Preparation of coated particles using a spray drying process with an aqueous system. Int. Journal of Pharmaceutics 1991; 77: 183–191
- Validation of analytical procedures. Methodology. International conference on the harmonization of technical requirements for the registration of pharmaceuticals for human use (ICH) Q2B. 1996
- Conte U., Conti B., Giunchedi P., Maggi L. Spray dried polylactide microsphere preparation: influence of the technological parameters. Drug Dev. Ind. Pharm. 1994; 20(3)235–258
- Bitz C., Doelker E. Influence of the preparation method on residual solvents in biodegradable microspheres. Int. J. Pharm. 1996; 131: 171–181
- López C.R., Fernández M.J.A. Microencapsulación de medicamentos. Tecnología Farmacéutica. Aspectos Fundamentales de los Sistemas Farmacéuticos y Operaciones Básicas, J.L.V. Jato. Síntesis, Madrid 1997; Vol. I: 577–608